OTCMKTS:GNWSD StageZero Life Sciences (GNWSD) Stock Price, News & Analysis $0.03 0.00 (0.00%) As of 06/20/2025 Add Compare Share Share Stock Analysis Stock AnalysisChartHeadlinesBuy This Stock About StageZero Life Sciences Stock (OTCMKTS:GNWSD) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get GNWSD alerts:Sign Up Key Stats Today's Range$0.03▼$0.0350-Day Range$0.00▼$0.0352-Week Range$0.17▼$0.89VolumeN/AAverage Volume4,987 shsMarket Capitalization$1.40 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewStageZero Life Sciences Ltd. engages in the development and commercialization of proprietary molecular diagnostic tests for detection of diseases and for personalized health management, with a focus on cancer-related indications. Its products includes Sentinel Principle, and ColonSentry. The company was founded by Choong-Chin Liew and K. Wayne Marshall in 1998 and is headquartered in Markham, Canada.Read More… Receive GNWSD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for StageZero Life Sciences and its competitors with MarketBeat's FREE daily newsletter. Email Address GNWSD Stock News HeadlinesBay Area life sciences campus hits the market after $20 million renovationNovember 13, 2024 | bizjournals.comWave Life Sciences Reveals RNA Editing Breakthrough, Reports First-Ever Clinical Proof-Of-Mechanism In HumansOctober 16, 2024 | benzinga.comA new rule goes live in July — and the banks are quietly cashing inA major change is quietly going into effect this July — and Wall Street is already positioning for it. Big Banks have found a way to use a new asset as if it were cash. Not stocks. Not bonds. Not even the U.S. dollar. They now trust this asset more than the traditional financial system itself.June 22, 2025 | American Alternative (Ad)Students explore life science during USD-501′s annual Kanza Science DaysOctober 1, 2024 | msn.comHow Boy Meets World ’s Ben Savage Views Maitland Ward's Porn CareerSeptember 25, 2024 | yahoo.comIncreased vacancy rates don't tell the full story when it comes to life sciences in ChicagoSeptember 24, 2024 | bizjournals.comPlano gives incentives for multi-billion dollar life science campus at former EDS siteAugust 28, 2024 | msn.comGreensboro Science Center howler monkey dies at 27 ‘surrounded by the love of her caretakers’August 18, 2024 | msn.comSee More Headlines GNWSD Stock Analysis - Frequently Asked Questions How have GNWSD shares performed this year? StageZero Life Sciences' stock was trading at $0.0016 at the start of the year. Since then, GNWSD stock has increased by 1,692.9% and is now trading at $0.0287. View the best growth stocks for 2025 here. How do I buy shares of StageZero Life Sciences? Shares of GNWSD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry N/A Sub-IndustryN/A Current SymbolOTCMKTS:GNWSD CIKN/A Webwww.stagezerolifesciences.com Phone(855) 420-7140FaxN/AEmployees80Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$3.48 million Net Margins217.39% Pretax MarginN/A Return on EquityN/A Return on Assets-61.21% Debt Debt-to-Equity RatioN/A Current Ratio0.09 Quick Ratio0.06 Sales & Book Value Annual Sales$140 thousand Price / Sales10.03 Cash FlowN/A Price / Cash FlowN/A Book Value($0.13) per share Price / Book-0.22Miscellaneous Outstanding Shares48,940,000Free FloatN/AMarket Cap$1.40 million OptionableNot Optionable Beta2.97 2025 Gold Forecast: A Perfect Storm for DemandUnlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free Report This page (OTCMKTS:GNWSD) was last updated on 6/22/2025 by MarketBeat.com Staff From Our Partners12 “perfect” stocksJoin the Dream Team and see how we can guarantee stock market wins Credentials are a good thing, especiall...Zacks | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhen This Happens, You Don’t Wait. You Act.This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredThe Biggest Story of My Decade-Long Career in Silicon ValleySteve Jobs' Lost 'Product' Could Save Tesla On July 21st, a revolutionary announcement could transform Tesl...InvestorPlace | Sponsored379 passengers walked away from thisForget OpenAI, ChatGPT, and the $2 trillion chip race… The real story is buried inside a new U.S. patent. E...True Market Insiders | SponsoredA grave, grave error.It seems like the world is on fire. Trump’s tariffs are crippling economies worldwide. Canada’s been cri...Porter & Company | SponsoredTrump Makes Major Crypto AnnouncementTrump's crypto revolution is now fully underway and now, we believe he’s about to deliver on his biggest promi...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding StageZero Life Sciences Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share StageZero Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
